Dive into Poolbeg Pharma's vision! #POLB001 is not just a treatment; it's a growth catalyst in the battle against Cytokine Release Syndrome post-immuno-oncology. Exploring vast markets and partnerships while navigating big pharma's tides. Insightful analysis here: https://lnkd.in/ectVBvmc #BiotechGrowth #HealthcareInnovation
Thank you to everyone who attended Monday's POLB 001 Oncology Programme Update! In case you missed it, you can watch it here: https://lnkd.in/exxr56Rn Highlights: 👨⚕️The challenges in safely and effectively delivering cancer immunotherapies to patients by Dr Martin Kaiser 💪 A myeloma patients’ perspective from Bob Munro 🔬 POLB 001 as a potential treatment for Cytokine Release Syndrome associated with cancer #immunotherapies #oncology #treatment #myeloma #POLB